ConditionCancer

Thyroid Cancer

Thyroid cancer is cancer of the thyroid gland at the front of the neck. It usually appears as a painless lump or nodule, often found during an exam or scan, and most people feel well. Papillary thyroid cancer, the most common type, grows slowly and has excellent survival. Diagnosis uses ultrasound and a fine-needle biopsy. Treatment is usually surgery, sometimes followed by radioactive iodine and thyroid hormone. Rare types, such as medullary and anaplastic cancer, behave differently and need specialist care.

Also called: Thyroid carcinoma, papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, anaplastic thyroid cancer

At a glance

What it is
Cancer arising from thyroid cells, usually as a nodule.
Main types
Papillary (about 80 percent), follicular, oncocytic (Hürthle cell), medullary, anaplastic.
Symptoms
Often none; a painless neck lump, hoarseness, difficulty swallowing, swollen neck nodes.
Diagnosis
Thyroid ultrasound, fine-needle aspiration biopsy, sometimes molecular testing.
Treatment
Surgery (lobectomy or total thyroidectomy), radioactive iodine for some, thyroid hormone, surveillance for small low-risk cancers.
Outlook
5-year survival is about 98 percent overall; much lower for anaplastic cancer.

When to get help

Call 911 or go to the ER

  • Difficulty breathing, noisy breathing or inability to swallow with a neck swelling
  • A rapidly enlarging neck mass over days with breathing or swallowing difficulty

See a doctor within a day or two

  • A hard, fixed neck lump that is growing over weeks
  • New hoarseness with a neck lump
  • Swollen lymph nodes in the neck with a thyroid nodule
  • Tingling around the mouth or muscle cramps after thyroid surgery (low calcium)

Book a routine appointment

  • A lump in the front of the neck, or a thyroid nodule found on a scan
  • A family history of thyroid cancer or MEN2, or radiation to the neck in childhood
  • Difficulty swallowing pills, or a feeling of pressure in the neck

What thyroid cancer is

The thyroid makes hormones that control metabolism. Thyroid nodules are very common, found on ultrasound in up to half of adults, and more than 90 percent are benign. A small proportion are cancer.

Thyroid cancer has become more commonly diagnosed partly because ultrasound and CT detect small cancers that may never cause harm. It is about three times more common in women and is often diagnosed between ages 30 and 60.

Types of thyroid cancer

TypeShareFeaturesOutlook
PapillaryAbout 80 percentSlow-growing, may spread to neck nodesExcellent
FollicularAbout 10 percentCan spread through blood to lungs or boneVery good
Oncocytic (Hürthle cell)3 to 5 percentVariant of differentiated cancerGood
Medullary1 to 2 percentFrom C cells; makes calcitonin; about 1 in 4 inherited (RET gene, MEN2)Good if caught early
AnaplasticUnder 2 percentVery aggressive, older adultsPoor

Papillary, follicular and oncocytic cancers are called differentiated thyroid cancers.

Risk factors

  • radiation exposure to the head and neck, especially in childhood
  • family history of thyroid cancer
  • Hashimoto's thyroiditis, which is linked to a higher risk of papillary cancer and thyroid lymphoma
  • inherited syndromes: multiple endocrine neoplasia type 2 (medullary cancer), familial adenomatous polyposis, Cowden syndrome
  • female sex
  • iodine deficiency (follicular cancer)
  • obesity

Symptoms

Many thyroid cancers cause no symptoms and are found by chance. Possible signs:

  • a lump or swelling in the front of the neck
  • swollen lymph nodes in the neck
  • hoarseness or voice changes that persist
  • difficulty swallowing or breathing
  • persistent cough not caused by a cold
  • neck or throat pain, sometimes spreading to the ears
  • diarrhea or flushing with advanced medullary cancer (from calcitonin)

Thyroid function tests are usually normal.

Diagnosis

  1. Thyroid blood tests: TSH to check function
  2. Ultrasound: assesses the nodule's size and features. Suspicious features include solid, darker (hypoechoic) appearance, irregular edges, microcalcifications and being taller than wide. Ultrasound risk systems such as ACR TI-RADS guide which nodules need biopsy
  3. Fine-needle aspiration (FNA) biopsy: results are reported in Bethesda categories from benign to malignant
  4. Molecular testing of indeterminate biopsies helps decide between surgery and monitoring
  5. Calcitonin and CEA blood tests and RET gene testing for medullary cancer
  6. Neck ultrasound of lymph nodes and sometimes CT before surgery

Treatment

Surgery

  • Lobectomy: removing one side of the thyroid, often enough for small, low-risk cancers confined to one lobe
  • Total thyroidectomy: removing the whole gland for larger or higher-risk cancers
  • Lymph node dissection when nodes are involved

Active surveillance

For very small (under 1 cm), low-risk papillary cancers without spread, monitoring with regular ultrasound is an accepted alternative to immediate surgery for some people.

Radioactive iodine (RAI)

Given after total thyroidectomy for some intermediate- and high-risk differentiated cancers, to destroy remaining thyroid tissue and cancer cells. It is not used for medullary or anaplastic cancer.

Thyroid hormone therapy

Levothyroxine replaces thyroid hormone after total thyroidectomy and, at adjusted doses, can suppress TSH, which may help prevent recurrence in higher-risk cancers.

Advanced or resistant cancer

  • targeted drugs such as lenvatinib, sorafenib, cabozantinib, and RET, BRAF or NTRK inhibitors for specific gene changes
  • external beam radiation
  • for anaplastic cancer, urgent multidisciplinary treatment combining surgery, radiation, chemotherapy and targeted drugs

Side effects of surgery

  • low calcium from injury to the parathyroid glands, usually temporary
  • hoarseness from injury to the recurrent laryngeal nerve, usually temporary
  • lifelong thyroid hormone replacement after total thyroidectomy

Follow-up

Regular neck ultrasound and blood tests for thyroglobulin (for differentiated cancer) or calcitonin and CEA (for medullary cancer) detect recurrence. Most recurrences can be treated successfully.

Outlook

According to the American Cancer Society, 5-year relative survival for thyroid cancer is about 98 percent overall: over 99 percent when confined to the thyroid, about 98 percent with spread to nearby nodes, and about 55 percent with distant spread. Papillary cancer has the best outlook. Anaplastic cancer has a poor prognosis.

Frequently asked questions

What are the first signs of thyroid cancer?

The most common first sign is a painless lump in the front of the neck. Others include swollen neck lymph nodes, persistent hoarseness, difficulty swallowing and a feeling of pressure. Many thyroid cancers are found by chance on scans.

Is thyroid cancer curable?

Most thyroid cancers, especially papillary and follicular types, are highly curable with surgery and, when needed, radioactive iodine. Overall 5-year survival is about 98 percent. Anaplastic thyroid cancer is the exception and is much harder to treat.

Are thyroid nodules usually cancer?

No. Thyroid nodules are very common, and more than 90 percent are benign. An ultrasound and, when needed, a fine-needle biopsy determine which nodules need treatment.

Do I need my whole thyroid removed?

Not always. Small, low-risk cancers may be treated by removing one lobe, or in some cases by active surveillance. Larger or higher-risk cancers usually need total thyroidectomy. Your surgeon will discuss options based on size, spread and type.

Will I need thyroid hormone pills for life?

If your whole thyroid is removed, yes, you will need daily levothyroxine. After removal of one lobe, many people make enough hormone on their own, though some still need a small dose.

Sources

This guide was written from current patient and clinical guidance, including:

  • American Thyroid Association: 2015 Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
  • American Cancer Society: Thyroid Cancer
  • National Cancer Institute: Thyroid Cancer Treatment (PDQ)
  • NCCN Guidelines for Patients: Thyroid Cancer
  • American Thyroid Association: Medullary Thyroid Cancer guidelines